Boule Diagnostics AB (publ) (STO: BOUL)
Sweden
· Delayed Price · Currency is SEK 8.88
-0.02 (-0.22%)
Dec 20, 2024, 5:12 PM CET
Boule Diagnostics AB Market Cap
Boule Diagnostics AB has a market cap or net worth of 344.84 million as of December 20, 2024. Its market cap has decreased by -12.94% in one year.
Market Cap
344.84M
Enterprise Value
505.94M
Revenue
563.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.88
Market Cap Chart
Since June 23, 2011, Boule Diagnostics AB's market cap has increased from 162.45M to 344.84M, an increase of 112.27%. That is a compound annual growth rate of 5.73%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,234.95B |
| Swedish Orphan Biovitrum AB (publ) | 106.60B |
| Sectra AB (publ) | 52.85B |
| Getinge AB (publ) | 47.62B |
| Camurus AB (publ) | 33.79B |
| Medicover AB (publ) | 29.34B |
| Vitrolife AB (publ) | 29.03B |
| Bonesupport Holding AB (publ) | 25.19B |